Adding Veliparib Extends Time Without Disease Progression in Metastatic Ovarian Cancer, Phase 3 Trial Finds
News
Using veliparib in combination with chemotherapy as first-line and then maintenance therapy post-surgery significantly extended the time without disease progression in women with newly diagnosed metastatic high-grade serous (HGS) ovarian ... Read more